Yuflyma 40 mg
Yuflyma 40 mg is a medicine authorised by Swissmedic under authorisation number 68515. The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 June 2022 and the authorisation is limited until 21 June 2027. ATC code L04AB04 places the medicine in the group Immunosuppressants.
| Authorisation number | 68515 |
|---|---|
| Name | Yuflyma 40 mg |
| Full name | Yuflyma 40 mg, solution injectable en stylo prérempli |
| Authorisation holder | IQONE HEALTHCARE SWITZERLAND SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AB04 |
| First authorisation | 22 June 2022 |
| Authorisation validity | 21 June 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Yuflyma 40 mg, solution injectable en stylo prérempli | B | 22 June 2022 |
| 2 | Yuflyma 80 mg, solution injectable en stylo prérempli | B | 27 April 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 0.4 ml | Injektor(en), vorgefüllt/Pen | L04AB04 | 07.15.0. | B |
| 2 | 2 x 0.4 ml | Injektor(en), vorgefüllt/Pen | L04AB04 | 07.15.0. | B |
| 4 | 2 x 0.4 ml | Injektor(en), vorgefüllt/Pen | L04AB04 | 07.15.0. | B |
| 3 | 1 x 0,8 ml | Injektor(en), vorgefüllt/Pen | L04AB04 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Yuflyma 40 mg authorised in Switzerland?
Yes. Yuflyma 40 mg is authorised by Swissmedic under authorisation number 68515, data as of 01 September 2026. The authorisation is limited until 21 June 2027.
Which dispensing category does Yuflyma 40 mg have?
Yuflyma 40 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Yuflyma 40 mg?
The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.